Report cover image

Generics in India

Publisher MarketLine
Published Dec 12, 2024
Length 46 Pages
SKU # MTLN19647762

Description

Generics in India

Summary

Generics in India industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
  • The Indian generics market recorded revenues of $22.8 billion in 2023, representing a compound annual growth rate (CAGR) of 7.2% between 2018 and 2023.
  • Market consumption volume increased with a CAGR of 0.4% between 2018 and 2023, to reach a total of 75.0% of total pharma volume in 2023.
  • The growth in India’s generics market is driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer, which require long-term treatment. A 2023 study by the Indian Council of Medical Research (ICMR) highlighted that 101 million people in India have diabetes, highlighting the increasing demand for affordable medications.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in India
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in India
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the India generics market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the India generics market by value in 2023?
  • What will be the size of the India generics market in 2028?
  • What factors are affecting the strength of competition in the India generics market?
  • How has the market performed over the last five years?
  • Who are the top competitors in India's generics market?

Table of Contents

46 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths and strategies of the leading players?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Sun Pharmaceutical Industries Ltd
8.2. Cipla Ltd
8.3. Aurobindo Pharma Ltd
8.4. Lupin Ltd
8.5. Dr. Reddy's Laboratories Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: India generics market value: $ million, 2018-23
Table 2: India generics market volume: % of total pharma volume, 2018-23
Table 3: India generics market geography segmentation: $ million, 2023
Table 4: India generics market value forecast: $ million, 2023-28
Table 5: India generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Sun Pharmaceutical Industries Ltd: key facts
Table 7: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Sun Pharmaceutical Industries Ltd: Key Employees
Table 9: Cipla Ltd: key facts
Table 10: Cipla Ltd: Annual Financial Ratios
Table 11: Cipla Ltd: Key Employees
Table 12: Aurobindo Pharma Ltd: key facts
Table 13: Aurobindo Pharma Ltd: Annual Financial Ratios
Table 14: Aurobindo Pharma Ltd: Key Employees
Table 15: Lupin Ltd: key facts
Table 16: Lupin Ltd: Annual Financial Ratios
Table 17: Lupin Ltd: Key Employees
Table 18: Dr. Reddy's Laboratories Ltd: key facts
Table 19: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
Table 20: Dr. Reddy's Laboratories Ltd: Key Employees
Table 21: India Size of Population (million), 2019-23
Table 22: India Real GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 23: India GDP (Current Prices, $ Billion), 2019-23
Table 24: India Inflation, 2019-23
Table 25: India Consumer Price Index (Absolute), 2019-23
Table 26: India Exchange Rate, 2018-23
List of Figures
Figure 1: India generics market value: $ million, 2018-23
Figure 2: India generics market volume: % of total pharma volume, 2018-23
Figure 3: India generics market geography segmentation: % share, by value, 2023
Figure 4: India generics market value forecast: $ million, 2023-28
Figure 5: India generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in India, 2023
Figure 7: Drivers of buyer power in the generics market in India, 2023
Figure 8: Drivers of supplier power in the generics market in India, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in India, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in India, 2023
Figure 11: Drivers of degree of rivalry in the generics market in India, 2023
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.